 |
| The topic of this article may not meet Wikipedia's
general notability guideline. (December 2023) |
| Incheol Shin | |
| Hangul | 신인철 |
|---|---|
| Revised Romanization | Sin Incheol |
| McCune–Reischauer | Sin Inch'ŏl |
Incheol Shin is a South Korean cancer researcher and, since 2005, a faculty member at the Department of Life Science, College of Natural Science, Hanyang University, Seoul, Republic of Korea. He was formerly a post-doc and then research faculty at Vanderbilt Ingram Cancer Center in Nashville, Tennessee, U.S.A. [1]
Publications
- I Shin; FM Yakes; F Rojo; NY Shin; AV Bakin; J Baselga; CL Arteaga (16 September 2002). "PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization" (PDF). Nature Medicine. 8 (10). Nature Medicine: 1145–52. doi: 10.1038/nm759. PMID 12244301. S2CID 19954112.
- Bong Gu Kang; June Ho Shin; Jae Kyu Yi; Ho Chul Kang; Jong Joo Lee; Hyen Seok Heo; Ji Hyung Chae; Incheol Shin; Chul Geun Kim (May 2007). "Corepressor MMTR/DMAP1 is Involved in both Histone Deacetylase 1- and TFIIH-Mediated Transcriptional Repression". Molecular and Cellular Biology. 27 (10). American Society for Microbiology: 3578–3588. doi: 10.1128/MCB.01808-06. PMC 1899998. PMID 17371848.
- Incheol Shin; Jeniffer Ed; Swati Biswas; P. Charles Lin; Raymond Mernaugh; Carlos L. Arteaga (April 1, 2005). "Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies". Cancer Research. 65 (7). Cancer Research: 2815–2824. doi: 10.1158/0008-5472.CAN-04-2898. PMID 15805282.
References
- ^ "Breast – Functional Proteomics Center Korea Institute of Science and Technology (Coordinating Center)". Team Members and Expertise – Incheol SHIN, Ph.D. (Hanyang University). Fred Hutchinson Cancer Research Center.
 | This article about a South Korean scientist is a stub. You can help Wikipedia by expanding it. |
|
| The topic of this article may not meet Wikipedia's
general notability guideline. (December 2023) |
| Incheol Shin | |
| Hangul | 신인철 |
|---|---|
| Revised Romanization | Sin Incheol |
| McCune–Reischauer | Sin Inch'ŏl |
Incheol Shin is a South Korean cancer researcher and, since 2005, a faculty member at the Department of Life Science, College of Natural Science, Hanyang University, Seoul, Republic of Korea. He was formerly a post-doc and then research faculty at Vanderbilt Ingram Cancer Center in Nashville, Tennessee, U.S.A. [1]
Publications
- I Shin; FM Yakes; F Rojo; NY Shin; AV Bakin; J Baselga; CL Arteaga (16 September 2002). "PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization" (PDF). Nature Medicine. 8 (10). Nature Medicine: 1145–52. doi: 10.1038/nm759. PMID 12244301. S2CID 19954112.
- Bong Gu Kang; June Ho Shin; Jae Kyu Yi; Ho Chul Kang; Jong Joo Lee; Hyen Seok Heo; Ji Hyung Chae; Incheol Shin; Chul Geun Kim (May 2007). "Corepressor MMTR/DMAP1 is Involved in both Histone Deacetylase 1- and TFIIH-Mediated Transcriptional Repression". Molecular and Cellular Biology. 27 (10). American Society for Microbiology: 3578–3588. doi: 10.1128/MCB.01808-06. PMC 1899998. PMID 17371848.
- Incheol Shin; Jeniffer Ed; Swati Biswas; P. Charles Lin; Raymond Mernaugh; Carlos L. Arteaga (April 1, 2005). "Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies". Cancer Research. 65 (7). Cancer Research: 2815–2824. doi: 10.1158/0008-5472.CAN-04-2898. PMID 15805282.
References
- ^ "Breast – Functional Proteomics Center Korea Institute of Science and Technology (Coordinating Center)". Team Members and Expertise – Incheol SHIN, Ph.D. (Hanyang University). Fred Hutchinson Cancer Research Center.
|
| This article about a South Korean scientist is a stub. You can help Wikipedia by expanding it. |